Omega 3 Supplements Market (By Source: Fish Oil, Krill Oil, Algae Oil; By Form: Tablets, Capsules, Soft Gels, Others; By Functionality: Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes; By End-use: Adults, Geriatric, Pregnant Women, Children, Infants; By Distribution Channel: OTC, Prescribed) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Omega 3 Supplements Market, By Source

7.1.  Omega 3 Supplements Market, by Source, 2021-2030

7.1.1.    Fish Oil

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Krill Oil

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Algae Oil

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Omega 3 Supplements Market, By Form

8.1.  Omega 3 Supplements Market, by Form, 2021-2030

8.1.1.    Tablets

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Capsules

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Soft Gels

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Others

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Omega 3 Supplements Market, By Functionality

9.1.  Omega 3 Supplements Market, by Functionality, 2021-2030

9.1.1.    Cardiovascular Health

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Brain, Nervous System & Mental Health

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Eye Diseases

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Diabetes

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Omega 3 Supplements Market, By End-user

10.1.        Omega 3 Supplements Market, by End-user, 2021-2030

10.1.1.  Adults

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Geriatric

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Pregnant Women

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Children

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Infants

10.1.5.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Omega 3 Supplements Market, By Distribution Channel

11.1.        Omega 3 Supplements Market, by Distribution Channel, 2021-2030

11.1.1.  OTC

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  Prescribed

11.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Omega 3 Supplements  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Source (2017-2030)

12.1.2.  Market Revenue and Forecast, by Form (2017-2030)

12.1.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.1.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.1.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.1.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.1.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.1.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.1.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.1.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.1.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Source (2017-2030)

12.2.2.  Market Revenue and Forecast, by Form (2017-2030)

12.2.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.2.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.8.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.8.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.8.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Source (2017-2030)

12.2.9.2.      Market Revenue and Forecast, by Form (2017-2030)

12.2.9.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.2.9.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.2.9.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Source (2017-2030)

12.3.2.  Market Revenue and Forecast, by Form (2017-2030)

12.3.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.3.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.8.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.8.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.8.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Source (2017-2030)

12.3.9.2.      Market Revenue and Forecast, by Form (2017-2030)

12.3.9.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.3.9.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.3.9.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Source (2017-2030)

12.4.2.  Market Revenue and Forecast, by Form (2017-2030)

12.4.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.4.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.8.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.8.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.8.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Source (2017-2030)

12.4.9.2.      Market Revenue and Forecast, by Form (2017-2030)

12.4.9.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.4.9.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.4.9.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Source (2017-2030)

12.5.2.  Market Revenue and Forecast, by Form (2017-2030)

12.5.3.  Market Revenue and Forecast, by Functionality (2017-2030)

12.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

12.5.5.  Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Source (2017-2030)

12.5.6.2.      Market Revenue and Forecast, by Form (2017-2030)

12.5.6.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.5.6.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Source (2017-2030)

12.5.7.2.      Market Revenue and Forecast, by Form (2017-2030)

12.5.7.3.      Market Revenue and Forecast, by Functionality (2017-2030)

12.5.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

12.5.7.5.      Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 13.  Company Profiles

13.1.              Nordic Naturals, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              NutriGold Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Reckitt Benckiser Group plc

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Pharma Nord B.V

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              i-Health, Inc.

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Aker BioMarine AS

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Luhua Biomarine (Shandong) Co., Ltd.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Pharmavite LLC

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              KD Pharma Group

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           NOW Foods

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

15.2.              Glossary of Terms